FdaApplication
ANDA 213165
Identifiers
- fda_app_no: ANDA213165
Properties
| Property | Value |
|---|---|
| applicant_name | CIPLA LTD |
| application_type | ANDA |
| approval_date | 2026-02-02 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LENALIDOMIDE | LENALIDOMIDE | 15MG | CAPSULE;ORAL |
| LENALIDOMIDE | LENALIDOMIDE | 25MG | CAPSULE;ORAL |
| LENALIDOMIDE | LENALIDOMIDE | 10MG | CAPSULE;ORAL |
| LENALIDOMIDE | LENALIDOMIDE | 20MG | CAPSULE;ORAL |
| LENALIDOMIDE | LENALIDOMIDE | 5MG | CAPSULE;ORAL |
5 products